Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EBOS Group Limited ( (AU:EBO) ) just unveiled an announcement.
EBOS Group Limited reported strong revenue growth and operational excellence for the 2025 financial year, driven by strategic acquisitions and expansion in the healthcare and animal care sectors. The company reinforced its leading market positions in New Zealand, Australia, and Southeast Asia, despite facing near-term macroeconomic pressures. Significant investments in capability and capacity are expected to support future growth and profitability, with the company well-positioned for long-term success due to supportive market trends.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care industries, providing a diversified portfolio of products and services. It is a leading pharmaceutical wholesaler in Australia and New Zealand, and a major player in healthcare-focused contract logistics and medical technology distribution across New Zealand, Australia, and Southeast Asia. The company also operates the largest dry dog food brand by volume in the pet specialty category in New Zealand and Australia, and manages leading vet wholesale businesses in both countries.
Average Trading Volume: 138,557
Technical Sentiment Signal: Sell
Current Market Cap: A$5.13B
For an in-depth examination of EBO stock, go to TipRanks’ Overview page.